Our new facility, in the world-renowned Research Triangle Park, is the flagship laboratory for IQVIA Laboratories. This custom-designed, 160,000-square-foot facility houses a suite of scientific solutions for bioanalytical, vaccine, biomarker and genomics laboratories. The site is also home to our new Translational Science and Innovation Laboratory (TSAIL).
As an industry leader clinical trial laboratory services, IQVIA Laboratories can help you make informed development decisions about your drug candidates by offering an array of high-throughput ADME screening and DMPK services that use validated bioanalytical methods to support candidate identification and characterization. Our scientists have extensive expertise with high-throughput discovery bioanalysis and LC/MS bioanalysis platforms that enable various aspects of ADME testing and pharmacokinetic (PK) testing. From in vitro ADME screening assays and drug-drug interaction risk assessment to metabolite identification of in vitro and in vivo samples, IQVIA Laboratories’ services facilitate rapid drug discovery ADME property optimization and regulatory filings.
Whatever your needs, however complex the problem, IQVIA Laboratories stands ready to develop a solution. Together, we can turn hope into help.
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Automation within an ADME Laboratory
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)
Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
